Sg2 Blog

As part of Sg2’s value-based care (VBC) analysis and market research, we review the quarterly earnings calls from a subset of publicly traded legacy payers and VBC-focused entrants. The summary is designed to highlight emerging trends and dynamics in these closely related industries, especially as they tie to VBC. The following post draws from recently released earnings call transcripts fro...

Editor’s note: This post was originally published on Sg2’s parent company Vizient Inc’s blog. For most of 2020, COVID-19 disrupted and significantly altered the infrastructure of the world’s industries, including health care delivery and services. But at what level can we expect health care to return to pre-pandemic levels? What are the long-term effects of the pandemic ev...

Health care organizations have turned the corner on pandemic recovery and are now strongly focused on strategy and investment. Day-to-day operations have stabilized for most. But the industry’s competitive landscape has irrevocably shifted, and the performance gap between the best and worst has widened. Health systems must chart this new territory with less capital, which makes strategy&mdas...

As children's hospitals and providers of complex pediatric care emerge from the pandemic, we have seen familiar challenges and priorities tenaciously reemerge. Chronic inadequacies in pediatric behavioral health service delivery, combined with pandemic-induced disruption and stress, have worsened today's acute pediatric mental health crisis. The rising prevalence and severity of pediatric behavior...

Medicare’s new Enhancing Oncology Model (EOM) is an important opportunity for oncology practices to participate in a voluntary alternative payment model (APM) designed to increase the value of care for Medicare fee-for-service (FFS) patients undergoing chemotherapy. This five-year model not only builds on the Oncology Care Model (OCM) and offers incentives to manage care while reducing spend...

Editor’s note: Answers have been edited for clarity. Sg2 was formed in 2001, and, today, our cutting-edge expertise, analytics and tailored consulting offerings help health industry leaders anticipate health care trends and provide them with unparalleled insight into local market dynamics. We are just one of the companies that founder Michael Sachs started—and grew—with his visio...

Clinical and technological advances continuously reshape healthcare services and the workforce that delivers them. In a cycle of creative destruction, new roles emerge while some legacy positions are reconsidered. Multiple drivers will also impact workforce needs in coming decades. Examples include an older and more diverse population, environmental impacts that disproportionately affect vulnerabl...

Editor’s note: this post was originally published on Sg2’s parent company Vizient Inc’s blog. Frustrated with high costs, a growing number of self-insured companies are considering going in a different direction: contracting directly with high-performing health systems for their employees’ specialty care. Aiming for healthier, more productive employees and lower costs, ind...

With the Strategy Accelerator program, efforts to strategically prioritize care at home programs for deployment take shape. Amid increasing inpatient lengths of stay; capacity limitations; and pressure from competitors, policy makers, payers and patients, the forces pointing to care at home as an opportunity continue to mount. However, success requires careful planning and analysis to craft a tail...

Editor’s note: Joe Cummings, PhD, Vizient Technology Program Director, authored this post, which was originally published on Sg2’s parent company Vizient Inc’s blog. The COVID-19 pandemic has had a significant effect on our country’s most vulnerable populations, from who gets the SARS-CoV-2 virus to its impact on mental health and access to care. For example, the pandemic ...